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Cellular Senescence: Minireview
Mitotic Clock or Culture Shock?
transferred along with the rest until, eventually, the cul-
tures no longer expand.
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INK4a/ARF locus and remain pseudodiploid. The rea-
sons for the ploidy differences remain unclear. Nonethe-
less, establishment routinely occurs before noticeable
ploidy changes, and the karyotypic alterations charac-
Primary mammalian cells have a finite life span in tissue teristic of immortalized cell lines are not essential for
culture, suggesting that there may be intrinsic mecha- this process (Todaro and Green, 1963). MEFs derived
nisms that count cell divisions, and that cellular ªsenes- from p53 null or ARF null animals maintain their high
cenceº may reflect aspects of organismal aging. Both proliferative potential, do not senesce, and can be prop-
human and mouse cells have been used to study replica- agated indefinitely (Kamijo et al., 1997), but cells lacking
tive growth arrest, although each system has its pecu- Rb or p21Cip1 arrest (Zindy et al., 1998; Pantoja and Ser-
liarities. Human fibroblasts, for example, have a more rano, 1999). Hence, disruption of p53 function, either
extended proliferative potential than their mouse coun- through mutation of p53 itself or by perturbing genes
terparts in culture, yet rarely become adapted to contin- such as ARF or Mdm2 that regulate p53, allows MEFs
uous growth as permanent cell lines (ªestablishmentº). to efficiently bypass the block to continuous replication
They are more resistant than rodent cells to oncogene- (Figure 1).
mediated transformation and tend to be more stable Primary MEFs exposed to oncogenic Ras overexpress
chromosomally. Despite these obvious differences, the the same panoply of cell cycle regulatory proteins nor-
temptation has been to link conclusions drawn from mally associated with arresting cells and undergo ªpre-
studies in these different cell systems, equating senes- mature senescenceº (Serrano et al., 1997), whereas es-
cence in mouse and human cells. Here, we consider the tablished variants lacking p53 or ARF are efficiently
idea that senescence of cultured cells results from two transformed (Kamijo et al., 1997). At the core of onco-
sources of signals, either of which can induce the ex- gene folklore, studies in the early 1980s by Ruley, Wein-
pression of a common set of inhibitors of the cell division berg, and their colleagues revealed that primary cell
cycle. One set of triggers is extrinsic and stems from strains would undergo transformation if an ªimmortaliz-
stresses that cells experience when they are explanted ing oncogeneº such as c-myc or adenovirus E1A was
into culture (ªculture shockº). The second class is intrin- cointroduced with oncogenic Ras. One property of these
sic and depends instead upon the machinery that moni- immortalizing oncoproteins is to activate the ARF-Mdm2-
tors the integrity of chromosomal telomeres (a potential p53 checkpoint, which senses inappropriate mitogenic
ªmitotic clockº). We suggest that differences in the pro- signals and diverts the cells to undergo p53-dependent
liferative capacity of cultured mouse and human cells apoptosis. This surveillance process is imperfect in the
reflect the extent to which they respond to these signal- sense that overexpression of Myc or E1A selects for
ing pathways. emergence of variants that have lost ARF or p53 func-
Mouse Cell Senescence: Is Culture the Culprit? tion; such cells are not only resistant to apoptosis but
ªWhen mammalian (mouse) cells are placed in culture, also more susceptible to transformation by Ras alone
they grow rapidly, often at a rate substantially exceeding (Zindy et al., 1998).
that in the intact animal. However, this growth does not There is no conclusive evidence that the replicative
continue indefinitelyº (Todaro and Green, 1963). Their arrest experienced by primary rodent fibroblasts in cul-
proliferative capacity dwindles and eventually ceases, ture depends upon a biologic clock that measures gen-
and the cells express elevated levels of negative cell eration number. Instead, the progressive loss in prolifer-
cycle regulators, including the CDK inhibitors p16INK4a ative capacity may result from cumulative trauma imposed
and p21Cip1, the p53 inducer p19ARF, and p53 itself. Ex- by tissue culture per se. We have been conditioned to
planted mouse embryonic fibroblasts (MEFs) stop divid- think that cell culture is a benign process, but nonphysi-
ing after only 15±30 generations when placed on a 3T3 ologic conditions including disruption of cell±cell con-
protocol. This procedure entails plating 3 3 105 cells tacts, lack of heterotypic interactions between different
(the second ª3º) in a culture dish, allowing them to ex- cell types, the medium-to-cell ratio, persistent Ras acti-
pand, and then transferring them (T) to a new dish three vation by mitogens, absence of appropriate survival fac-
days later (the first ª3º). Regardless of their total number, tors, hyperoxia, and plating on plastic are likely to induce
cells harvested at each passage are rediluted to 3 3 105 stress responses. If this is correct, then cells grown
before replating. Those that have ceased growing are under more physiologic conditions might well proliferate
much longer (Loo et al., 1987). At least some insults
induced by the culture environment may lead to DNA³ To whom correspondence should be addressed (e-mail: sherr@
stjude.org). damage and checkpoint activation. Cultured MEFs that
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have lost DNA damage sensors such as Atm, for exam- synthesizing telomere repeats (TTAGGG in mammals)
at the 39 ends of chromosomal DNA (Greider and Black-ple, sustain a high level of chromosomal breakage, im-
burn, 1996). Despite the fact that telomere erosion canplying that ªbackgroundº levels of damage-inducing sig-
trigger DNA damage-induced checkpoints, there is nonals are significant but are normally offset by active
strong evidence suggesting that the replicative arrestrepair processes. Atm null cells manifest a greatly re-
of mouse cells after only 15±30 population doublings induced proliferative capacity in culture, and their ªprema-
culture depends upon telomere attrition. Telomeres areture senescenceº is bypassed by p53 loss (Westphal et
quite long in laboratory mouse strains, and the prolifera-al., 1997). A consequence is that the ªrescuedº doubly
tive block occurs well before there is detectable telo-deficient cells are even more genetically unstable, exhib-
mere shortening. Moreover, many somatic mouse tis-iting frequent chromatid strand breaks and undergoing
sues and cultured cells express telomerase activity,chromosomal aneuploidy, fragmentation, and rearrange-
suggesting that the enzyme may not be rate limitingment. Independent of the nature of the accumulated
as mouse cells senesce (Prowse and Greider, 1995).damage, disabling the ARF-Mdm-p53 checkpoint ap-
Assuming that its only function is to extend telomeres,pears to be central to the establishment of cultured
telomerase overexpression in MEFs should not affectMEF-derived lines.
their proliferative capacity. However, this has not yetBy contrast, the need for disruption of the p16INK4a±
been formally tested.cyclin D/CDK±Rb pathway in bypassing senescence re-
Human Telomere Erosion: A Mitotic Clockmains a subject of some debate. Mouse fibroblasts en-
Cultured primary human fibroblasts seem to behave dif-forced to overexpress cyclin D±dependent kinases and
ferently. These strains also have a finite capacity forthose lacking Rb still undergo replicative arrest. How-
division in cell culture (Hayflick and Moorhead, 1961),ever, it is more difficult to gauge the contribution of
but compared to MEFs, they are capable of many more cellp16INK4a loss. A complication is that both p16INK4a and
divisions (60±80 doublings) before reaching the ªHayflickp19ARF are encoded by a single locus, in part through
limitº and undergoing senescence. The simplest inter-overlapping reading frames, and results with mice lack-
pretation of their extended proliferative potential in cul-ing p16INK4a but retaining p19ARF have not yet been re-
ture might be that human fibroblasts have developedported. Nonetheless, there is some reason to believe
more efficient mechanisms to repair the damage im-that fibroblasts lacking only p16INK4a undergo replicative
posed by the culture environment. Indeed, there is aarrest, based upon the finding that Balb/c mice harbor a
loose correlation between the longevity of cell strainsmutated INK4a allele that exhibits compromised p16INK4a
and the life span of a species (Rohme, 1981). Nonethe-biochemical function (Zhang et al., 1998). This p16INK4a
less, establishing primary human cells as continuouslymutation was deduced to render Balb/c mice prone to
proliferating cell lines is extremely difficult, occurring atdevelopment of carcinogen-induced B cell tumors, but
frequencies that are orders of magnitude lower than thosetheir MEFs do not seem to exhibit an extended life span
observed with cultured mouse cells. Another cardinalin culture (in contradistinction to those from engineered
difference is that oncoproteins such as SV40 T antigenknockout strains lacking ARF or p53). Therefore, loss of
that neutralize the functions of both p53 and Rb extendRb pathway function appears insufficient for fibroblast
the proliferative capacity of human cells but are insuffi-establishment. Still, the possibility that this is required
cient to immortalize them (Wright and Shay, 1992). Whatfor immortalization of other cell types cannot be pre-
other barriers must be overcome?cluded. Moreover, the effects of p16INK4a mutation may
Human telomeres are much shorter than those in labo-well be subtler than those resulting from ARF loss. Anti-
ratory mice (z12 kb versus z60 kb), and telomerase issense neutralization of either p16INK4a or p19ARF in primary not normally expressed in most human cells, the notable
MEFs from CD1 mice increased their efficiency of estab- exceptions being ªimmortalº germ cells and some tissue
lishment, although p16INK4a antisense was less effective. stem and progenitor cells. Therefore, over the course
In late-passage cells simultaneously expressing anti- of many cell divisions, shortened telomeres may initiate
sense RNAs to both p16INK4a and p19ARF, restoration of DNA damage responses, activating p53- and Rb-depen-
p16INK4a expression had no effect on proliferation, whereas dent checkpoints that contribute to senescence (Figure
reconstitution of p19ARF function led to cell cycle arrest 1). If checkpoint arrest is corrupted by viral oncoproteins
(Carnero et al., 2000). Such observations beg the ques- or mutations, cells should continue to proliferate until
tion of whether p19ARF loss might compromise the func- they reach ªcrisis,º a stage at which many chromosomes
tions of both p53 and Rb. Whatever the interplay be- have undergone telomere erosion and from which only
tween the Rb and p53 pathways, it seems evident that rare survivors emerge. Crisis connotes a state of mas-
rodent fibroblasts rely most strongly on the p53 check- sive chromosomal instability, resulting from end-to-end
point to limit their establishment in culture (Figure 1). (Robertsonian) chromosomal fusions, and fusion±bridge±
What about telomere attrition in immortalized mouse breakage cycles or nondisjunctions during mitosis, leading
cells? DNA polymerases function in the 59-to-39 direction to genetic catastrophe and cell death. Immortalization may
and require both a template and a primer for synthesis, require that human cells solve problems imposed by
predicting that the ends of chromosomal DNA are pro- telomere dysfunction, either by reactivating telomerase
gressively shortened over the course of many rounds or by employing an alternative (ALT) recombinational
of DNA replication (actually 50±100 bp per cell division). mechanism to maintain telomeres and, hence, chromo-
A widely held view is that critically short telomeres, as somal integrity (Figure 1). These mechanisms restabilize
well as those otherwise lacking structures dependent chromosomes and enable cells to weather crisis.
upon telomere binding proteins, eventually come to re- The notion that telomere shortening and/or dysfunc-
semble unprotected DNA ends that must be repaired tion limits the longevity of human cells in culture comes
through end joining, frequently involving chromosome from experiments in which senescence was bypassed
fusions. Replication of chromosome ends normally in- by enforcing expression of the telomerase catalytic sub-
volves telomerase, a specialized reverse transcriptase unit (TERT) in normal diploid fibroblasts, thereby en-
dowing them with an apparently infinite life span (Bodnarcontaining an RNA subunit that provides a template for
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Figure 1. Pathways to Senescence in Mouse and Human Cells
et al., 1998). Importantly, TERT-rescued fibroblasts re- p21Cip1 were significantly higher than those detected in
normal MEFs at equivalent passage levels, and fewermain diploid and appear to be genetically stable, arguing
that whatever other forms of nontelomere-based DNA cells were in cycle. Therefore, telomere attrition in MEFs
can lead to a p53 response and, as might be expected,damage might limit the growth of human cells in culture,
the damaged DNA is efficiently detected and repaired. the proliferative block is ameliorated in cells derived
from generationally matched animals lacking both mTRNot all human cell types may be so endowed, since
certain epithelial cells, for example, have a more limited and p53. The latter cells have an extended survival but
exhibit a greater number of end-to-end chromosomeproliferative capacity in culture, and in this setting inacti-
vation of Rb or p16 function, but not p53 loss, comple- fusions in comparison to mTR null cells that retained
p53 function (Chin et al., 1999). Removing the telomerements TERT reconstitution in the immortalization pro-
cess (Kiyono et al., 1998). Still, it is fair to question binding protein TRF2 in mouse cells also generates an
ATM-dependent signal that activates p53 (Karlsederwhether the culture conditions for such cells are optimal,
and whether TERT rescue would prove sufficient for et al., 1999). Hence, when mouse telomeres become
dysfunctional, exposed chromosomal termini and/or re-immortalization under other circumstances.
The vast majority of established human cell lines have sulting fusion±bridge±breakage events generate DNA
damage signals that induce p53-dependent cell cyclebeen derived from advanced human neoplasms that
express telomerase. In tumors arising from most human arrest or apoptosis. This behavior of cultured late-gener-
ation mTR-deficient mouse cells more closely resem-somatic cells, disruption of the Rb and p53 pathways
should serve to extend cellular life span before telo- bles the response of primary human cells entering crisis
(Figure 1).merase is reactivated. On the other hand, the order of
events is likely inverted in telomerase-positive germ cell Reviewing the Variables
In summary, we propose that replicative arrest in mousetumors and in some hematopoietic malignancies arising
from stem cells. Even though escape from senescence and human cells depends in part on a differential re-
sponse to the tissue culture environment. Mouse cellsand crisis are important events in the life history of hu-
man cancer cells, the presence of telomerase activity may be relatively more sensitive to culture shock, be-
cause shorter-lived rodents may not have evolved theper se reflects an immortal state but not an oncogeni-
cally transformed one that requires other contributing putatively more effective damage repair machinery that
typifies longer-lived humans. Whether cell senescencemutations (Hanahan and Weinberg, 2000).
Mouse Cells without Telomerase occurs in vivo, possibly as a response to cumulative
damage signals, and whether such a process has any-Telomerase-deficient mice have been generated by de-
letion of the mTR gene, which encodes the RNA compo- thing to do with organismal aging remain unresolved
issues.nent of the enzyme (Blasco et al., 1997). Due to the very
long telomeres of Mus musculus, the effects of telomere MEFs can be immortalized by subverting p53 function,
whereas disruption of the Rb pathway appears inade-shortening only become noticeable following extensive
passages of mTR null cells and after successive genera- quate for establishment. By contrast, primary human
fibroblasts have a greater proliferative capacity thantions of breeding. Telomere shortening leads to genetic
instability in late-generation mTR null mice and results MEFs, but they are considerably more difficult to immor-
talize. Bypassing the p53 and Rb checkpoints is insuffi-in testicular germ cell depletion, uterine and intestinal
villus atrophy, diminished hematopoietic stem cell func- cient for their establishment but prolongs their life span.
Resulting telomere dysfunction ultimately precipitatestion, impaired mitogenic responses of lymphocytes, and
dermatitis. As during the DNA damage response, p53 crisis, which can be bypassed through telomerase reac-
tivation. mTR null mouse cells (and mice for that matter)activation in this setting can trigger either cell cycle
arrest or apoptosis depending on cell type and collateral appear unperturbed unless bred through multiple gener-
ations, arguing strongly that telomerase is dispensablesignals.
In early passage MEFs derived from late-generation for senescence of cultured mouse cells. On the other
hand, observations that late-generation mTR null cellsmTR null animals, the levels of p53 and p53-responsive
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with shortened telomeres (Chin et al., 1999) or cells with
otherwise disrupted telomere structures (Karlseder et
al., 1999) initiate p53-dependent DNA damage re-
sponses lend support to the idea that aberrant chromo-
some ends, like broken chromosomes, signal through
common checkpoint regulators. Although there is no
conclusive evidence that telomere shortening per se
triggers senescence in human cells, the fact that TERT
overexpression can immortalize fibroblasts without a
requirement for disrupted p53 and Rb functions is
strongly indicative. A caveat is that ectopic TERT ex-
pression might provide other as yet unknown functions
apart from telomere elongation. Moreover, other cell
types (e.g., keratinocytes) behave differently, although
an open question is whether the conditions chosen for
their culture are adequate to avoid activation of check-
point responses. It should come as no shock that multi-
ple pathways appear capable of eliciting a senescence
response, with human and mouse cells exhibiting dis-
tinct dependencies on them.
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